Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA), Pub. L. No. 112-144, §1127, 126 Stat. 993, 1117-18 ((July 9, 2012).
The Act expands the FDA's authorities and strengthens the agency's ability to safeguard and advance public health.
The Act required that the GAO report on problems posed by rogue Internet pharmacies. This report identifies (1) how rogue Internet pharmacies are selling prescription drugs in violation of federal or state law or established industry standards, (2) challenges associated with federal investigations and prosecutions of rogue Internet pharmacies, (3) efforts to combat rogue Internet pharmacies, and (4) efforts to educate consumers about the risks of rogue Internet pharmacies and how to recognize legitimate online pharmacies.
The Act also included a provision that the GAO report on the FDA's progress in developing and [implement]]ing an IT strategic plan, and to report on actions taken by the agency to address the other IT-related recommendations resulting from the GAO's prior reports in 2009 and 2012.